Clinical Trials Directory

Trials / Completed

CompletedNCT04497246

Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)

Status
Completed
Phase
Study type
Observational
Enrollment
1,150 (actual)
Sponsor
Murielle Surquin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

COVID-19 is an infectious disease caused by the last coronavirus discovered, called SARS-CoV-2. Symptoms encountered in COVID-19 are: cough, breathing difficulties (dyspnea, chest pain, etc.), pyrexia, anosmia (loss of smell) and/or dysgeusia (loss of taste), but also ENT symptoms (rhinitis type, odynophagia), headaches, asthenia, muscle pain, confusion and diarrhea. Infection with SARS-CoV-2 can also be asymptomatic. COVID-19 can be passed from person to person by respiratory droplets expelled when a person speaks, coughs or sneezes. The currently estimated incubation period ranges from 1 to 14 days, and most often this is around 5 days. According to a literature review, there is strong evidence that COVID-19 has an impact on mental health (anxiety being the most common symptom) whether in the general population, healthcare workers or vulnerable populations. The objective of this project is to assess mental health and sleep disorders within two populations: elderly patients and nursing staff.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireData collection by means of various questionnaires

Timeline

Start date
2020-05-29
Primary completion
2021-08-20
Completion
2021-08-20
First posted
2020-08-04
Last updated
2022-04-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04497246. Inclusion in this directory is not an endorsement.